Page 95 - Read Online
P. 95

Page 4 of 11          Dixit et al. J Cancer Metastasis Treat 2022;8:47  https://dx.doi.org/10.20517/2394-4722.2022.70

                                          • Drug resistance
                                          Induces Apoptosis
                miR-16-  Low    No        Inhibits      Tumor    • BCL-2, CCND1, PD-L1  -    Subcutaneous
                5p [33-35,50,55]          • Proliferation   suppression                      xenograft** Phase
                                          • Clonogenicity                                    II clinical trial -
                                          • Drug resistance                                  planned †
                                          Induces
                                          • G0/G1 cell cycle
                                          arrest
                                          • Apoptosis
                miR-   Low      High      Inhibits proliferation  Tumor   • MCL-1, PD-L1  -  Subcutaneous
                193a-           expression =   Induces    suppression                        xenograft**
                3p [34,36]      better survival • Apoptosis
                                          • Necrosis
                Modulate cell metabolism
                miR-126- Low    -         Inhibits      Tumor    • IRS1, VEGF-A, PDK,   -    Subcutaneous
                 [38,39,56]
                3p                        • Mitochondrial   suppression ACL                  xenograft*
                                          function
                                          • Angiogenesis
                                          Induces autophagy
                Inhibit oncogenes
                miR-   Low      -         Inhibits      Tumor    • KRAS, EGFR, VEGF-A,  -    Subcutaneous and
                206 [40,51]               • Proliferation  suppression IGF1R, CDK4, CDK6,    intrapleural
                                          •Migration/invasion    CCND1, c-MET                xenograft
                                          Induces
                                          • G1/S cell cycle
                                          arrest
                                          • Senescence

               All miRNAs are named according to their sequence identity in miRBase (release 22.1; Available from: www.mirbase.org), which may defer from
                                           #
               their nomenclature in the original articles.  Low in biphasic and sarcomatoid histological subtypes; *although mouse flank xenografts were
               reported, the MPM cell line had been transfected beforehand with miR-145-5p and then grafted into the mouse; **systemic delivery of miRNA;
               †                  [50]
                as indicated by the reference  .

               Re-expression of miR-1294 suppressed MPM cell proliferation, migration/invasion, and clonogenicity by
               downregulating HMGA1. Interestingly, miR-1294 expression is influenced by the circular RNA (circRNA)
               polo-like kinase 1 (circPLK1) in MPM progression . circRNAs are closed noncoding RNAs generated by
                                                          [12]
               back-splicing of exons from precursor pre-mRNAs. circRNAs are widely expressed in mammalian cells in
               tissue-specific patterns and regulate various biological processes. circPLK1 directly binds miR-1294 by
               complementary base pairing to sequester its expression in MPM. This reciprocal relationship has been
               observed in gene profiling studies where circPLK1 was overexpressed with concomitant miR-1294
               downregulation.

               MIRNAS THAT INDUCE CELL CYCLE ARREST AND APOPTOSIS
               A microarray analysis of 31 human samples (25 MPM tumors and 6 normal pleura) was performed to
               identify global miRNA signatures. miR-1-3p was among the top downregulated miRNAs in human MPM
               tumors compared with normal pleura (6.6-fold) . miR-1-3p inhibited MPM cell proliferation and induced
                                                        [13]
               G1/S cell cycle arrest and apoptosis. Re-expression of miR-1-3p modulated the expression of signaling
               molecules that impact cell cycle progression and apoptosis such as p16, p21, p53, BAX, BCL-2, and Survivin.
               Another physiologic effect of miR-1-3p was inhibition of cell migration and invasion by downregulating the
               proto-oncogene PIM-1, a serine/threonine-protein kinase .
                                                               [14]

               MIRNAS ASSOCIATED WITH P53
               Unlike other solid epithelial tumors, there is a low frequency (approximately 9%) of p53 mutations in MPM
               irrespective of histotype . However, p53 functionality is bypassed, wherein 50% to 75% of MPM tumors
                                    [15]
   90   91   92   93   94   95   96   97   98   99   100